Industry: Chemical & Material
Published Date: 2024-09-15
Pages: 119 Pages
Report ld: 3321767
Request Sample
Customized Report
Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size(US$)

CAGR 2024-2030
5%
Market Size,2030
USD 1,157
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) revenue was US$ 815 million in 2023 and is forecast to a readjusted size of US$ 1157 million by 2030 with a CAGR of 5.0% during the review period (2024-2030).
In United States the Pharmaceutical Grade Polyethylene Glycol (PEG) revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Pharmaceutical Grade Polyethylene Glycol (PEG) market, also covers the segmentation data of other regions in regional level and county level.
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is experiencing steady growth, driven by its widespread application in the pharmaceutical, biotechnology, and personal care industries. PEG is valued for its versatility, biocompatibility, and non-toxicity, making it an essential component in a variety of drug formulations.
1. Growth in the Biopharmaceutical Sector
PEGylation: PEG is widely used in biopharmaceuticals through a process known as PEGylation, where PEG chains are attached to therapeutic molecules like proteins or peptides to enhance their stability, reduce immunogenicity, and extend their half-life. With the increasing development of biologics and biosimilars, the demand for PEG in these applications is rising.
Monoclonal Antibodies and Proteins: The growing use of monoclonal antibodies (mAbs) and therapeutic proteins in treating chronic diseases like cancer, autoimmune disorders, and genetic conditions is driving demand for PEG, which helps improve the pharmacokinetics of these drugs.
2. Increasing Application in Drug Delivery Systems
Oral, Injectable, and Topical Formulations: PEG is commonly used in various drug delivery systems, including oral, injectable, and topical formulations. Its solubility and ability to improve drug bioavailability make it a preferred excipient in many pharmaceutical products. The rising demand for innovative drug delivery systems is boosting the PEG market.
Controlled and Sustained Release Formulations: PEG is also used in controlled-release formulations to enhance drug stability and modulate the release of active ingredients. As the pharmaceutical industry focuses on developing long-acting formulations, the role of PEG in these systems is expanding.
4. Expansion in the Pharmaceutical Industry
Pharmaceutical Excipients: PEG serves as an important excipient in a wide range of pharmaceutical formulations, including tablets, capsules, and ointments. Its role in improving drug solubility and absorption is critical, particularly for poorly soluble drugs. The continued growth of the pharmaceutical industry, driven by an aging population and the rise in chronic diseases, is contributing to increased demand for pharmaceutical-grade PEG.
Over-the-Counter (OTC) Medications: PEG is commonly used in laxatives and stool softeners. With the increase in the prevalence of gastrointestinal issues and other digestive disorders, particularly in developed markets, the demand for PEG-based OTC medications is growing.
5. Growing Focus on Sustainable and Bio-Based PEG
Sustainability Initiatives: There is an increasing trend toward using bio-based PEG derived from renewable resources due to growing environmental concerns and regulations. Manufacturers are focusing on developing eco-friendly, sustainable alternatives to traditional petrochemical-based PEG, which is expected to gain traction in the pharmaceutical and personal care industries.
Regulatory Compliance: With the tightening of environmental and safety regulations in several regions, the focus on green chemistry and sustainable production methods is becoming more important. Companies investing in the production of bio-based or biodegradable PEG will benefit from this shift.
Pharmaceutical Grade Polyethylene Glycol (PEG) market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Pharmaceutical Grade Polyethylene Glycol (PEG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Pharmaceutical Grade Polyethylene Glycol (PEG) market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Pharmaceutical Grade Polyethylene Glycol (PEG) definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Pharmaceutical Grade Polyethylene Glycol (PEG) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Pharmaceutical Grade Polyethylene Glycol (PEG) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Grade Polyethylene Glycol (PEG) sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Product Introduction
1.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Outlook 2019 VS 2023 VS 2030
1.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in US$ Million for the Year 2019-2030
1.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume for the Year 2019-2030
1.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Outlook 2019 VS 2023 VS 2030
1.3.1 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in US$ Million for the Year 2019-2030
1.3.2 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume for the Year 2019-2030
1.4 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Pharmaceutical Grade Polyethylene Glycol (PEG) in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Dynamics
1.5.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Industry Trends
1.5.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Drivers
1.5.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Challenges
1.5.4 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Pharmaceutical Grade Polyethylene Glycol (PEG) by Type
2.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Market by Type
2.1.1 Mw (<1000)
2.1.2 Mw (1000-10000)
2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Type
2.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Type
2.3.1 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Pharmaceutical Grade Polyethylene Glycol (PEG) by Application
3.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Market by Application
3.1.1 Tablets
3.1.2 Capsules
3.1.3 Liquids
3.1.4 Injectables
3.1.5 Topicals
3.1.6 Others
3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Application
3.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Application
3.3.1 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Competitor Landscape by Company
4.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Company
4.1.1 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Ranked by Revenue (2023)
4.1.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Manufacturer (2019-2024)
4.1.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Manufacturer (2019-2024)
4.1.4 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Price by Manufacturer (2019-2024)
4.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Concentration Ratio (CR)
4.2.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG) in 2023
4.2.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Product Offered and Application
4.5 Global Key Manufacturers of Pharmaceutical Grade Polyethylene Glycol (PEG), Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Company
4.7.1 Key Players of Pharmaceutical Grade Polyethylene Glycol (PEG) in United States, Ranked by Revenue (2023)
4.7.2 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Revenue by Players (2019-2024)
4.7.3 United States Pharmaceutical Grade Polyethylene Glycol (PEG) Sales by Players (2019-2024)
5 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Region
5.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size in Volume by Region (2019-2030)
5.2.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume by Region: 2019-2024
5.2.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume Forecast by Region (2025-2030)
5.3 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size in Value by Region (2019-2030)
5.3.1 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value by Region: 2019-2024
5.3.2 Global Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size YoY Growth 2019-2030
6.2 Americas Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Pharmaceutical Grade Polyethylene Glycol (PEG) Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size YoY Growth 2019-2030
7.2 EMEA Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Pharmaceutical Grade Polyethylene Glycol (PEG) Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size YoY Growth 2019-2030
8.2 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Pharmaceutical Grade Polyethylene Glycol (PEG) Market Size YoY Growth 2019-2030
9.2 APAC Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Pharmaceutical Grade Polyethylene Glycol (PEG) Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Pharmaceutical Grade Polyethylene Glycol (PEG) Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 BASF
10.1.1 BASF Company Information
10.1.2 BASF Description and Business Overview
10.1.3 BASF Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.1.4 BASF Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.1.5 BASF Recent Development
10.2 Dow Chemical
10.2.1 Dow Chemical Company Information
10.2.2 Dow Chemical Description and Business Overview
10.2.3 Dow Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Dow Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.2.5 Dow Chemical Recent Development
10.3 Croda
10.3.1 Croda Company Information
10.3.2 Croda Description and Business Overview
10.3.3 Croda Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Croda Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.3.5 Croda Recent Development
10.4 Clariant
10.4.1 Clariant Company Information
10.4.2 Clariant Description and Business Overview
10.4.3 Clariant Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Clariant Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.4.5 Clariant Recent Development
10.5 Ineos
10.5.1 Ineos Company Information
10.5.2 Ineos Description and Business Overview
10.5.3 Ineos Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Ineos Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.5.5 Ineos Recent Development
10.6 India Glycols
10.6.1 India Glycols Company Information
10.6.2 India Glycols Description and Business Overview
10.6.3 India Glycols Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.6.4 India Glycols Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.6.5 India Glycols Recent Development
10.7 Shandong Ruisheng
10.7.1 Shandong Ruisheng Company Information
10.7.2 Shandong Ruisheng Description and Business Overview
10.7.3 Shandong Ruisheng Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.7.4 Shandong Ruisheng Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.7.5 Shandong Ruisheng Recent Development
10.8 Jiangxi Yipusheng
10.8.1 Jiangxi Yipusheng Company Information
10.8.2 Jiangxi Yipusheng Description and Business Overview
10.8.3 Jiangxi Yipusheng Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.8.4 Jiangxi Yipusheng Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.8.5 Jiangxi Yipusheng Recent Development
10.9 Liaoning Huaxing Chemical
10.9.1 Liaoning Huaxing Chemical Company Information
10.9.2 Liaoning Huaxing Chemical Description and Business Overview
10.9.3 Liaoning Huaxing Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Liaoning Huaxing Chemical Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.9.5 Liaoning Huaxing Chemical Recent Development
10.10 Petronas Chemicals
10.10.1 Petronas Chemicals Company Information
10.10.2 Petronas Chemicals Description and Business Overview
10.10.3 Petronas Chemicals Pharmaceutical Grade Polyethylene Glycol (PEG) Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Petronas Chemicals Pharmaceutical Grade Polyethylene Glycol (PEG) Products Offered
10.10.5 Petronas Chemicals Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Industry Chain Analysis
11.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Pharmaceutical Grade Polyethylene Glycol (PEG) Production Mode & Process
11.4 Pharmaceutical Grade Polyethylene Glycol (PEG) Sales and Marketing
11.4.1 Pharmaceutical Grade Polyethylene Glycol (PEG) Sales Channels
11.4.2 Pharmaceutical Grade Polyethylene Glycol (PEG) Distributors
11.5 Pharmaceutical Grade Polyethylene Glycol (PEG) Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 902 million in 2025 and is forecast to reach a readjusted size of US$ 1263 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market was valued at US$ 902 million in 2025 and is anticipated to reach US$ 1263 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 133
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 902 million in 2025 and is projected to reach US$ 1263 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 100
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 80
USD 4250.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is projected to grow from US$ 863 million in 2024 to US$ 1209 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
In 2024, the global market size of Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million and is forecast to reach approximately US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 140
USD 5900.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 110
USD 3950.00
(Single User License)
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was valued at US$ 863 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-18
Pages: 92
USD 2900.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 98
USD 3950.00
(Single User License)
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published Date: 2024-09-15
Pages: 136
USD 4900.00
(Single User License)
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 902 million in 2025 and is forecast to reach a readjusted size of US$ 1263 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market was valued at US$ 902 million in 2025 and is anticipated to reach US$ 1263 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 133
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 902 million in 2025 and is projected to reach US$ 1263 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-04
Pages: 100
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size was US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 80
The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is projected to grow from US$ 863 million in 2024 to US$ 1209 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 136
In 2024, the global market size of Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million and is forecast to reach approximately US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 140
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was estimated to be worth US$ 863 million in 2024 and is forecast to a readjusted size of US$ 1209 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 110
The global market for Pharmaceutical Grade Polyethylene Glycol (PEG) was valued at US$ 863 million in the year 2024 and is projected to reach a revised size of US$ 1209 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-18
Pages: 92
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 98
Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.
Published: 2024-09-15
Pages: 136
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now